ArticleJTCVS open2025

Real-world use of adjuvant nivolumab among patients with esophageal and gastroesophageal junction cancer at a large integrated health system.

Andrea M Gochi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.